OBRI publications that are not open access

Hepworth E, Movahedi M, Rampakakis E, Mirza R, Lau A, Cesta A, Pope J, Sampalis JS, Bombardier C. Changes in Market Share of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Results from the Ontario Best-Practice Research Initiative Database. Curr Rheumatol Rev. 2021;17(3):349-359. doi: 10.2174/1573397116666201211130337. PMID: 33308132.

Ahluwalia V,  Rampakakis E, Movahedi M, Cesta A, Li X, Couto S, Sampalis J, Bombardier C. Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: Results from the Ontario Best Practices Initiative. Clinical Rheumatology. November 2017, Volume 36, Issue 11, pp 241-2430. DOI: 10.1007/s10067-017-3805-4. Epub 2017 Sep 6. PMID: 28879413.

Ruban TN, Jacob B, Pope JE, Keystone EC, Bombardier C, Kuriya B. The influence of age at disease onset on disease activity and disability: results from the Ontario Best Practices Research Initiative. Clin Rheumatol. 2016 Mar;35(3):759-63. doi: 10.1007/s10067-015-3031-x. Epub 2015 Aug 6. PMID: 26245721.